Jason A. Roy

faculty photo
Associate Professor of Biostatistics in Biostatistics and Epidemiology at the Hospital of the University of Pennsylvania
Senior Scholar, Center for Clinical Epidemiology and Biostatistics (CCEB), University of Pennsylvania Perelman School of Medicine
Department: Biostatistics and Epidemiology

Contact information
Department of Biostatistics and Epidemiology
University of Pennsylvania Perelman School of Medicine
Room 629 Blockley Hall
423 Guardian Drive
Philadelphia, PA 19104
Office: 215-746-4225
Fax: 215-573-1050
Graduate Group Affiliations
Education:
B.S. (Actuarial Science and Economics)
Eastern Michigan University, 1995.
M.S. (Biostatistics)
University of Michigan, 1997.
Ph.D. (Biostatistics)
University of Michigan, 2000.
Permanent link
 

Description of Itmat Expertise

causal inference, pharmacoepidemiology, comparative effectiveness research

Selected Publications

Lo Re V 3rd, Carbonari DM, Lewis JD, Forde KA, Goldberg DS, Reddy KR, Haynes K, Roy JA, Sha D, Marks AR, Schneider JL, Strom BL, Corley DA.: Oral Azole Antifungal Medications and Risk of Acute Liver Injury, Overall and by Chronic Liver Disease Status. The American Journal of Medicine 129: 283-291, 2016.

Rhee EP, Clish CB, Wenger J, Roy J, Elmariah S, Pierce KA, Bullock K, Anderson AH, Gerszten RE, Feldman HI.: Metabolomics of Chronic Kidney Disease Progression: A Case-Control Analysis in the Chronic Renal Insufficiency Cohort Study. Am J Nephrol. 2016.

Hsu RK, Chai B, Roy JA, Anderson AH, Bansal N, Feldman HI, Go AS, He J, Horwitz EJ, Kusek JW, Lash JP, Ojo A, Sondheimer JH, Townsend RR, Zhan M, Hsu CY; CRIC Study Investigators: Abrupt Decline in Kidney Function Before Initiating Hemodialysis and All-Cause Mortality: The Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis 2016.

Xu S, Shetterly S, Cook AJ, Raebel MA, Goonesekera S, Shoaibi A, Roy J, Fireman B: Evaluation of propensity scores, disease risk scores, and regression in confounder adjustment for the safety of emerging treatment with group sequential monitoring. Pharmacoepidemiology & Drug Safety 25: 453-61, 2016.

Lash JP, Ricardo AC, Roy J, Deo R, Fischer M, Flack J, He J, Keane M, Lora C, Ojo A, Rahman M, Steigerwalt S, Tao K, Wolf M, Wright JT Jr, Go AS: Race/Ethnicity and Cardiovascular Outcomes in Adults With CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic CRIC Studies. Am J Kidney Dis 2016.

Ricardo AC, Roy JA, Tao K, Alper A, Chen J, Drawz PE, Fink JC, Hsu CY, Kusek JW, Ojo A, Schreiber M, Fischer MJ; CRIC Study Investigators: Influence of Nephrologist Care on Management and Outcomes in Adults with Chronic Kidney Disease. J Gen Intern Med 31: 22-29, 2016.

Navaneetha SD, Roy J, Tao K, Brecklin CS, Chen J, Deo R, Flack JM, Ojo AO, Plappert TJ, Raj DS, Saydain G, Sondheimer JH, Sood R, Steigerwalt SP, Townsend RR, Dweik RA, Rahman M: Prevalence, Predictors and Outcomes of Pulmonary Hypertension in Chronic Kidney Disease. Journal of the American Society of Nephrology 27: 877-86, 2016.

Roy J, Lum KJ, Daniels MJ.: A Bayesian nonparametric approach to marginal structural models for point treatments and a continuous or survival outcome. Biostatistics 2016.

Lo Re V 3rd, Gowda C, Urick PN, Halladay JT, Binkley A, Carbonari DM, Battista K, Peleckis C, Gilmore J, Roy JA, Doshi JA, Reese PP, Reddy KR, Kostman JR: Disparities in absolute denial of modern hepatitis C therapy by type of insurance. Clinical Gastroenterology and Hepatology 2016.

Raebel MA, Shetterly S, Lu CY, Flory J, Gagne JJ, Harrell FE, Haynes K, Herrinton LJ, Patorno E, Popovic J, Selvan M, Shoaibi A, Wang X, Roy J.: Methods for using clinical laboratory test results as baseline confounders in multi-site observational database studies when missing data are expected. Pharmacoepidemiol Drug Saf 2016.

back to top
Last updated: 05/24/2016
The Trustees of the University of Pennsylvania